APP and Alzheimer disease: Impairments in mitochondrial membrane potential and mitochondrial DNA damage also directly alter both amyloid precursor protein (APP) processing and amyloid beta (Aβ) plaque burden,8, 9 indicating a relationship between mitochondrial impairments and AD pathology.